# ICATIBANT ACETATE
> **ANDA208317** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2020-06-18
## Drug
- **FDA Application Number:** ANDA208317
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ICATIBANT ACETATE
- **Generic name:** ICATIBANT
- **Active ingredients:** ICATIBANT ACETATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2020-06-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208317)
---
*MORVS · CC0 1.0*